CClinicalTrials.gg
Enrolling by invitationNCT06489106Updated Feb 18, 2026

Noninvasive Spinal Stimulation to Restore Hand Function in Children With Spinal Cord Injury

An interventional study of Activity based upper extremity training with and without stimulation in Spinal Cord Injury Cervical, sponsored by University of Louisville. Enrolling by invitation at 1 site in United States. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by University of Louisville · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

The main goal of this pilot study is to find the best ways to use transcutaneous spinal cord stimulation (scTS) to improve hand function in children with spinal cord injuries (SCI). The investigators will start by exploring the best places and strengths for applying scTS on the neck, the added benefits of applying scTS on the lower back (T11-T12), and comparing the effects of using activity based upper extremity training (a control treatment) alone versus combining it with scTS to help children with chronic SCI regain hand function.

Read the detailed description

After learning about the study and potential risks, parents/legal guardians and their eligible children with SCI will sign consent and assent forms, respectively. For the first two aims of the study, the investigators will recruit and enroll 10 participants. In the first week, participants will undergo clinical assessments from day 1 to day 4 to categorize the severity and level of their injuries and assess their current arm and hand function. On day 5, eligible participants will have experimental assessments to measure hand grip and control, both with and without spinal cord stimulation (scTS) at one or two neck sites optimized to improve hand grip. On day 6, participants will have similar assessments, this time adding stimulation to the trunk area to help with upright sitting and study its impact on hand grip and control.

For the third aim, 4 participants who showed improved hand grip and control with stimulation in aims 1 and 2 will be selected on a first-come, first-served basis. They will undergo 20 sessions of activity-based upper extremity training, followed by 20 more sessions with the optimal stimulation sites identified from aims 1 and 2. After completing the training, participants will be asked to follow up and repeat experimental and clinical assessments to determine how long the improvements last.

02

Conditions studied

  • Spinal Cord Injury Cervical

Keywords

  • Pediatric onset
  • Transcutaneous spinal cord stimulation
  • Hand and arm function
  • Chronic spinal cord injury
03

In context

Lead sponsor

University of Louisville is the lead sponsor of 284 studies on the registry; 53 are open to participants now.

Of its 20 completed or terminated interventional studies of FDA-regulated products, 7 (35%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

For aim 1 and 2, 10 participants with SCI:

  1. age 7-12 years;
  2. chronic (>6 months), acquired upper motor neuron SCI;
  3. cervical SCI at or above C8 neurological level with motor score of 1-3 for finger flexors
  4. Pediatric Neurorecovery scale score of ≥2B and ≤ 4C for impaired grip

For Aim 3, 4 participants with SCI who:

  1. complete aim 1 and 2;
  2. consent/assent for aim 3
  3. demonstrate a minimum of 10% increase in HG force with scTS (aim1-2)
  4. confirmed volitional activation in hand muscles during hang grip assessment without scTS

Exclusion criteria

Exclusion Criteria:

For all 3 aims will include:

  1. Botox use within past 3 months (for upper or lower extremity);
  2. current oral baclofen (or pump);
  3. musculoskeletal impairment limiting range of motion;
  4. unhealed fracture or other medical condition limiting participation in AB-UET;
  5. etiology of spina bifida;
  6. total ventilator dependence.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Active comparator
    Activity based upper extremity training

    Activity-based upper extremity training (AB-UET) will be administered 5d/week and 1 hour 30 minutes/session.

    Device: Activity based upper extremity training with and without stimulation

  • Experimental
    Activity based upper extremity training with stimulation

    Activity-based upper extremity training (AB-UET + scTS) will be administered 5d/week and 1 hour 30 minutes/session. UE tasks will be repeated with and without scTS so that scTS is administered intermittently for the duration of \~ 10 minute/bouts.

    Device: Activity based upper extremity training with and without stimulation

Interventions

  • DeviceActivity based upper extremity training with and without stimulation

    Activity-based upper extremity training (AB-UET) will be administered 5d/week and 1 hour 30 minutes/session. For AB-UET+ stimulation (scTS), UE tasks will be repeated with and without scTS so that scTS is administered intermittently for the duration of \~ 10 minute/bouts.

06

What researchers measure

Primary outcomes

  1. Hand grip

    Voluntary maximal hand grip force

    Time frame: 12 weeks

  2. Hand control

    Peak to peak distance on hand grip force

    Time frame: 12 weeks

Secondary outcomes

  1. Functional neurophysiological assessment-Upper extremity

    Multi-muscle activation patterns

    Time frame: 12 weeks

  2. Pediatric Neurorecovery scale

    Pediatric Neurorecovery scale (NRS) is a validated clinical scale that assesses a child's (age 1-12 years) neuromuscular capacity to perform everyday tasks without behavioral compensation, physical assistance, or assistive device. The total score is the sum of all tasks on a scale from 1-12. For a total of 12 items, the highest score being 144 and lowest a sore of 12. Higher scores indicate improved function.

    Time frame: 12 weeks

  3. Capabilities of upper extremity test

    The Capabilities of the Upper Extremity Test (CUE-T) is a performance measure intended to assess upper extremity function following spinal cord injury. The CUE-T is an objective measure of the ability to complete actions and tasks involving the arm and hand in individuals with tetraplegia and can be used clinically, for research and in clinical trials. Respondents answer questions on a 7-point scale that represents their self-perceived difficulty in performing the action, with 1 indicating "totally limited, can't do at all" and 7 indicating "not at all limited". The total score is the sum of all responses, and ranges from 32 to 224, with higher scores indicating greater function.

    Time frame: 12 weeks

  4. Box and block test

    The Box and Block Test (BBT) measures unilateral gross manual dexterity and is validated in pediatric population. The score is the number of blocks carried from one compartment to the other in one minute. Each hand is scored separately. Higher scores within 1-minute indicate better manual dexterity.

    Time frame: 12 weeks

07

Study locations

1 site
  • Kentucky Spinal Cord Injury Research Center
    Louisville, Kentucky 40202, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06489106
Lead sponsor
University of Louisville
Collaborators
The Craig H. Neilsen Foundation
Responsible party
Goutam Singh (Assistant Professor, University of Louisville) — Principal investigator
First posted
Jul 5, 2024
Start date
Jun 13, 2025
Primary completion
Jul 31, 2026 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Feb 18, 2026

Study contacts

Goutam Singh, PhD
principal investigator · University of Louisville and Spalding University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion